The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management
Open accessAbstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystem involvement. It is multifactorial and involves epigenetic, genetic, ecological, and environmental factors. Primarily it leads to activation of both innate and adaptive immunity, which consequently leads to autoreactive B cell activation by T cells and leads to immune complexes deposition in tissues leading to an autoimmune cascade that may be limited to the single organ or can cause a widespread systemic involvement. SLE is heterogeneous in presentation, with a broad spectrum of clinical manifestations ranging from clinically mild self-resolving symptoms to severe life-threatening organ involvement. Clinical and serological heterogeneity are critical features in SLE, posing a significant challenge in its diagnosis. Antinuclear antibodies (ANA) are the telltale serological marker in more than 95% of SLE patients. The improved set of European Alliance of Associations for Rheumatology (EULAR) classification enabled accurate diagnosis of SLE. The treatment focuses on remission, preventing organ damage, and improving the overall quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX
(2007) · Systemic Lupus Erythematosus · doi:10.1016/b978-0-323-04434-9.50060-9 · Cited by 2,928
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40930 · Cited by 2,677
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215089 · Cited by 2,011
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Systemic Lupus Erythematosus Disease Activity Index
National Cancer Institute (2020) · Definitions · doi:10.32388/n5g0vc · Cited by 1,003
Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Rees, F., Doherty, M., Grainge, M. J., Lanyon, P., & Zhang, W. (2017) · Rheumatology · doi:10.1093/rheumatology/kex260 · Cited by 789
Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus
Al-Mayouf, S. M., Sunker, A., Abdwani, R., Abrawi, S. A., Almurshedi, F., Alhashmi, N., Al Sonbul, A., Sewairi, W., Qari, A., Abdallah, E., et al. (2011) · Nature Genetics · doi:10.1038/ng.975 · Cited by 490
Neuropsychiatric lupus: new mechanistic insights and future treatment directions
Schwartz, N., Stock, A. D., & Putterman, C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0156-8 · Cited by 429
Incidence of systemic lupus erythematosus race and gender differences
Mccarty, D. J., Manzi, S., Medsger, T. A., Ramsey‐Goldman, R., Laporte, R. E., & Kwoh, C. K. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380914 · Cited by 426
van Vollenhoven, R. F., Petri, M. A., Cervera, R., Roth, D. A., Ji, B. N., Kleoudis, C. S., Zhong, Z. J., & Freimuth, W. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200937 · Cited by 411
Genetic susceptibility to systemic lupus erythematosus in the genomic era
Deng, Y., & Tsao, B. P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.176 · Cited by 379
Hydroxychloroquine in systemic lupus erythematosus (SLE)
Ponticelli, C., & Moroni, G. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1269168 · Cited by 345
Cigarette smoking and the risk of systemic lupus erythematosus: A meta‐analysis
Costenbader, K. H., Kim, D. J., Peerzada, J., Lockman, S., Nobles‐Knight, D., Petri, M., & Karlson, E. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20049 · Cited by 333
Toll-like receptor signalling in B cells during systemic lupus erythematosus
Fillatreau, S., Manfroi, B., & Dörner, T. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00544-4 · Cited by 322
Weckerle, C. E., & Niewold, T. B. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8192-4 · Cited by 300
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
Poole, B. D., Scofield, R. H., Harley, J. B., & James, J. A. (2006) · Autoimmunity · doi:10.1080/08916930500484849 · Cited by 286
The complement system in systemic lupus erythematosus: an update
Leffler, J., Bengtsson, A. A., & Blom, A. M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205287 · Cited by 265
Anti-Ro/SSA and La/SSB antibodies
Franceschini, F., & Cavazzana, I. (2005) · Autoimmunity · doi:10.1080/08916930400022954 · Cited by 262
Glucocorticoid use and abuse in SLE
Ruiz-Irastorza, G., Danza, A., & Khamashta, M. (2012) · Rheumatology · doi:10.1093/rheumatology/ker410 · Cited by 248
Möckel, T., Basta, F., Weinmann-Menke, J., & Schwarting, A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102736 · Cited by 228
T cells in Systemic Lupus Erythematosus
Suárez-Fueyo, A., Bradley, S. J., & Tsokos, G. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.001 · Cited by 227
Alba, P., Bento, L., Cuadrado, M. J., Karim, Y., Tungekar, M. F., Abbs, I., Khamashta, M. A., D'Cruz, D., & Hughes, G. R. V. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.556 · Cited by 213
Disturbances of apoptotic cell clearance in systemic lupus erythematosus
Shao, W.-H., & Cohen, P. L. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3206 · Cited by 212
Mahajan, A., Amelio, J., Gairy, K., Kaur, G., Levy, R. A., Roth, D., & Bass, D. (2020) · Lupus · doi:10.1177/0961203320932219 · Cited by 211
A Review of Complement Activation in SLE
Weinstein, A., Alexander, R. V., & Zack, D. J. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00984-1 · Cited by 205
Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE
Su, D.-L., Lu, Z.-M., Shen, M.-N., Li, X., & Sun, L.-Y. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/347141 · Cited by 199
Deficiency of the type I interferon receptor protects mice from experimental lupus
Nacionales, D. C., Kelly‐Scumpia, K. M., Lee, P. Y., Weinstein, J. S., Lyons, R., Sobel, E., Satoh, M., & Reeves, W. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23023 · Cited by 194
Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
Didier, K., Bolko, L., Giusti, D., Toquet, S., Robbins, A., Antonicelli, F., & Servettaz, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00541 · Cited by 187
The Pathology of T Cells in Systemic Lupus Erythematosus
Mak, A., & Kow, N. Y. (2014) · Journal of Immunology Research · doi:10.1155/2014/419029 · Cited by 180
Haematological manifestations of systemic lupus erythematosus
Keeling, D. M., & Isenberg, D. A. (1993) · Blood Reviews · doi:10.1016/0268-960x(93)90006-p · Cited by 172
Belimumab: A Review in Systemic Lupus Erythematosus
Blair, H. A., & Duggan, S. T. (2018) · Drugs · doi:10.1007/s40265-018-0872-z · Cited by 161
Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus
Cook, H. T., & Botto, M. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0191 · Cited by 148
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region
Armstrong, D. L., Zidovetzki, R., Alarcón-Riquelme, M. E., Tsao, B. P., Criswell, L. A., Kimberly, R. P., Harley, J. B., Sivils, K. L. M., Vyse, T. J., Gaffney, P. M., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.23 · Cited by 146
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
Furie, R. A., van Vollenhoven, R., KALUNIAN, K. C., Navarra, S., Romero‐Díaz, J., Werth, V. P., Huang, X., Clark, G., Carroll, H., Meyers, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118025 · Cited by 146
Optimizing outcome in SLE: treating-to-target and definition of treatment goals
Doria, A., Gatto, M., Zen, M., Iaccarino, L., & Punzi, L. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.055 · Cited by 138
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future
Liu, C., Kao, A. H., Manzi, S., & Ahearn, J. M. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13485503 · Cited by 134
Drug-induced lupus: Traditional and new concepts
Vaglio, A., Grayson, P. C., Fenaroli, P., Gianfreda, D., Boccaletti, V., Ghiggeri, G. M., & Moroni, G. L. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.03.016 · Cited by 131
Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice
Brown, J. M., Archer, A. J., Pfau, J. C., & Holian, A. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02094.x · Cited by 130
Cytokine expression in lupus kidneys
Aringer, M., & Smolen, J. (2005) · Lupus · doi:10.1191/0961203305lu2053oa · Cited by 124
Grossman, J. M. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.04.003 · Cited by 122
Pathophysiology of cutaneous lupus erythematosus
Achtman, J. C., & Werth, V. P. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0706-2 · Cited by 117
Pragmatic approaches to therapy for systemic lupus erythematosus
Xiong, W., & Lahita, R. G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.157 · Cited by 117
Abnormal B Cell Development in Systemic Lupus Erythematosus
Karrar, S., & Graham, D. C. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40396 · Cited by 117
Clinical Manifestations of Cutaneous Lupus Erythematosus
Kuhn, A., Sticherling, M., & Bonsmann, G. (2007) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2007.06554.x · Cited by 113
Treatment Algorithms in Systemic Lupus Erythematosus
Muangchan, C., van Vollenhoven, R., Bernatsky, S., Smith, C. D., Hudson, M., İnanç, M., Rothfield, N. F., Nash, P. T., Furie, R. A., Senécal, J., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22589 · Cited by 110
Decrease of regulatory T cells in patients with systemic lupus erythematosus
Mellor‐Pita, S., Citores, M. J., Castejon, R., Tutor‐Ureta, P., Yebra-Bango, M., Andreu, J. L., & Vargas, J. A. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044974 · Cited by 109
Hematological Disorders in Patients with Systemic Lupus Erythematosus
Bashal, F. (2013) · The Open Rheumatology Journal · doi:10.2174/1874312901307010087 · Cited by 105
Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues
Porta, S., Danza, Ã., Saavedra, M. A., Carlomagno, A., Goizueta, M. C., Vivero, F., & Ruiz‐Irastorza, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092709 · Cited by 105
Chyuan, I., Tzeng, H., & Chen, J.-Y. (2019) · Cells · doi:10.3390/cells8090963 · Cited by 99
Urinary biomarkers in lupus nephritis
Aragón, C. C., Tafúr, R.-A., Suárez-Avellaneda, A., Martínez, M. T., Salas, A. S.-D. L., & Tobón, G. J. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100042 · Cited by 91
Immunologic and genetic considerations of cutaneous lupus erythematosus: A comprehensive review
Yu, C., Chang, C. C.-C., & Zhang, J. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.01.007 · Cited by 90
Altered B cell receptor signaling in human systemic lupus erythematosus
Jenks, S. A., & Sanz, I. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.047 · Cited by 86
Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus
Østensen, M., & Villiger, P. (2001) · Lupus · doi:10.1191/096120301668183556 · Cited by 82
Houssiau, F. A. A. A. A. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000140218.77174.0a · Cited by 80
ANA as an entry criterion for the classification of SLE
Pisetsky, D. S., Bossuyt, X., & Meroni, P. L. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102400 · Cited by 80
Clinical manifestations and survival among adults with (SLE) according to age at diagnosis
Merola, J. F., Bermas, B. L., Lü, B., Karlson, E. W., Massarotti, E. M., Schur, P. H., & Costenbader, K. H. (2014) · Lupus · doi:10.1177/0961203314526291 · Cited by 79
Pego‐Reigosa, J. M., Cobo‐Ibáñez, T., Calvo‐Alén, J., Loza‐Santamaría, E., Rahman, A., Muñoz‐Fernández, S., & Rúa‐Figueroa, Í. (2013) · Arthritis Care & Research · doi:10.1002/acr.22035 · Cited by 74
Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE
Berner, B. R., Tary‐Lehmann, M., Yonkers, N. L., Askari, A., Lehmann, P., & Anthony, D. D. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.06.010 · Cited by 71
Gastrointestinal manifestations in systemic lupus erythematosus
Fawzy, M., Edrees, A., Okasha, H., Ashmaui, A. E., & Ragab, G. (2016) · Lupus · doi:10.1177/0961203316642308 · Cited by 70
Luijten, R. K. M. A. C., Fritsch-Stork, R. D. E., Bijlsma, J. W. J., & Derksen, R. H. W. M. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.001 · Cited by 67
Jones, J. V. (1982) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00211-3 · Cited by 63
Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus
Su, Y., Jia, R., Han, L., et al. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.10.003 · Cited by 56
Antinuclear antibody—negative systemic lupus erythematosus
Provost, T. T., & Reichlin, M. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)70013-6 · Cited by 54
Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus
Fu, S. M., Dai, C., Zhao, Z., & Gaskin, F. (2015) · F1000Research · doi:10.12688/f1000research.6875.1 · Cited by 51
New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
Pagani, S., Bellan, M., Mauro, D., Castello, L. M., Avanzi, G. C., Lewis, M., Sainaghi, P. P., Pitzalis, C., & Nerviani, A. (2020) · Disease Markers · doi:10.1155/2020/1614627 · Cited by 42
Regulatory T Cells in SLE: Biology and Use in Treatment
Giang, S., & Cava, A. L. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0616-6 · Cited by 41
Wu, Z., Li, X., Qin, H., Zhu, X., Xu, J., & Shi, W. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.04.022 · Cited by 39
A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus
Gu, M., Wang, X., Cheng, Q., Zhao, Y., Zhang, T., Li, B., & Ye, D. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1567534 · Cited by 39
Jung, J., & Suh, C. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12568 · Cited by 38
Lim, K. L., Jones, A. C., BROWN, N. S., & Powell, R. J. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.6.429 · Cited by 37
Tanaka, Y. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101814 · Cited by 33
Clinical relevance of T follicular helper cells in systemic lupus erythematosus
Nakayamada, S., & Tanaka, Y. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1976146 · Cited by 32
Mechanistic insights into environmental and genetic risk factors for systemic lupus erythematosus.
Pan, Q., Chen, J., Guo, L., Lü, X., Liao, S., Zhao, C., Wang, S., & Liu, J. (2019) · Europe PMC (PubMed Central) · Cited by 29
Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus
Østensen, M., & Villiger, P. (2000) · Lupus · doi:10.1191/096120300678828794 · Cited by 27
Abdwani, R., Masroori, E. A., Abdullah, E., Abrawi, S. A., & Al-Zakwani, I. S. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00619-w · Cited by 26
Preclinical and early systemic lupus erythematosus
Gatto, M., Saccon, F., Zen, M., Iaccarino, L., & Doria, A. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.06.004 · Cited by 21
Deng, Y., & Tsao, B. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00005-0 · Cited by 14
Abnormalities in Immune Complex Clearance and Apoptotic Cell Clearance
Jorge, A. M., & Means, T. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00015-3 · Cited by 5
Metadata
- Authors
- Ameer, M. A., Chaudhry, H., Mushtaq, J., Khan, O. S., Babar, M., Hashim, T., Zeb, S., Tariq, M. A., Patlolla, S. R., Ali, J., Hashim, S. N., & Hashim, S.
- Venue
- Cureus
- Published
- 2022-10-15
- Volume
- 14
- Issue
- 10
- Pages
- e30330-e30330
- ISSN
- 2168-8184 (ISSN-L)
- OpenAlex
- W4306315823
- Cited by
- 346
- References
- 79
- FWCI
- 41.96
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.